A Phase IIb, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the safety, tolerability and efficacy of Study Drug in adults with chronic hepatitis C virus infection.
Persistence Leads To High Enrollment
A Phase IV, randomized, single-blind, placebo-controlled, multi-center study to evaluate the immunogenicity of pneumococcal and influenza vaccines in…
Ask the Experts: What Does the World Need to Know About TB?
According to the World Health Organization, Tuberculosis (TB) is the world’s leading infectious cause of death. Despite significant advances in…